Skip to main content
28 April 2024
Last updated:
Thursday 25 April 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Adaptive licensing: A new approach for drug approvals
Read more
IMI: As Big Pharma pulls back, IMI steps in
Read more
MRC Technology: Going global for local returns
Read more
EU Transparency Directive: changes afoot on pricing and reimbursement
Read more
How to strengthen the biopharma ecosystem
Read more
Planning for the Unified Patent Court
Read more
An analysis of accelerated approval for cancer drugs
Read more
Avastin vs Lucentis: the drug reimbursement dilemma of the century
Read more
EU pharmacovigilance law comes into force
Read more
Commentary on the impact of pharmacovigilance legislation
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
5
Page
6
Page
7
Page
8
Page
9
Current page
10
Page
11
Page
12
Page
13
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form